Naogen Pharma

Naogen Pharma, the future market leader in PET-rubidium-82 functional molecular imaging for better patient care in cardiology and oncology.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Saint-Herblain, France
  • Currency EUR
  • Founded September 2016
  • Employees 5
  • Incorporation Type Other
  • Website naogen-pharma.com

Company Summary

Naogen Pharma, created in 2016, is a company with an experienced management team stemming from French academic excellence in nuclear medicine. Naogen Pharma develops a Strontium / Rubidium-82 generator and injector, which allows Naogen Pharma to become the third global player in a global market of € 500M in 2023.
Corporate objectives include a first European Marketing Authorization in 2021 , the EU commercial launch in 2022.

Team

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free